Nerissa Kreher - 28 Oct 2021 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Medical Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
4
Filing time
01 Nov 2021, 19:00:07 UTC
Previous filing
14 Jul 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Award $0 +72,012 $0.000000 72,012 28 Oct 2021 Common stock 72,012 $20.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments commencing on October 28, 2021 (the "Vesting Start Date"), such that the option shares shall be fully vested on the four-year anniversary of the Vesting Start Date.